Sheldon Greenfield, MD, Discusses Integrating Quality Care Measures into Diabetes Management: Two Sides of the Coin
In light of ongoing healthcare reform in the US, Sheldon Greenfield, MD, the executive co-director of the Health Policy Research Institute and Donald Bren Professor of Medicine at the University of California Irvine School of Medicine, shared his insights on the role of quality care measures in the management of diabetes, and weighed in on the advantages and disadvantages associated with implementing these tools.
This video was taken at the American Diabetes Associations 73rd Scientific Sessions in Chicago, IL - See more at: http://www.ajmc.com/conferences/ada-2013/The-Role-of-Testosterone-Supplementation-in-Men-with-Diabetes#sthash.nZpe1vzr.dpuf
In light of ongoing healthcare reform in the US, Sheldon Greenfield, MD, the executive co-director of the Health Policy Research Institute and Donald Bren Professor of Medicine at the University of California Irvine School of Medicine, shared his insights on the role of quality care measures in the management of diabetes, and weighed in on the advantages and disadvantages associated with implementing these tools.
This video was taken at the American Diabetes Associations 73rd Scientific Sessions in Chicago, IL.
This video was taken at the American Diabetes Associations 73rd Scientific Sessions in Chicago, IL - See more at: http://www.ajmc.com/conferences/ada-2013/The-Role-of-Testosterone-Supplementation-in-Men-with-Diabetes#sthash.nZpe1vzr.dpuf
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025
- Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD
September 17th 2025
- Assessing the Rising Prevalence of Early-Onset Type 2 Diabetes in the US
September 16th 2025